28523479|t|Fatty Acids Have Different Adipogenic Differentiation Potentials in Stromal Vascular Cells Isolated from Abdominal Fat in Laying Hens
28523479|a|This study was conducted to examine the effects of fatty acids (FA) with/without chicken serum (CS) on the expression of adipogenic transcripts and adipogenesis in chicken stromal vascular cells (SVC). In experiment 1, SVC were grown in DMEM containing 10% FBS (Control) and treated with 300 µM oleic acid (OLA) + FBS, linoleic acid (LNA) + FBS, palmitic acid (PAM) + FBS, or stearic acid (STA) + FBS for 48 h. In experiment 2, cells were grown in DMEM containing 5% CS and treated with 300 µM OLA (CS + OLA), PAM (CS + PAM), STA (CS + STA) or 200 µM LNA (CS + LNA) for 48 h. Adipogenesis was determined using Oil Red O staining and glycerol-3-phosphate dehydrogenase (GPDH) activity. The proportion of OLA, PAM, or STA was increased (P < 0.05) in SVC grown in either FBS or CS with OLA, PAM or STA. Adipogenesis was induced in FBS + OLA, FBS + LNA, FBS + PAM, FBS + STA, CS + OLA, CS + LNA, CS + PAM, or CS + STA compared to FBS. GPDH activity was significantly higher in FBS + OLA and FBS + LNA than one in FBS. Compared to FBS, the expression of FABP4 mRNA increased (P < 0.05) in FBS + OLA, FBS + LNA, or FBS + PAM, whereas that of C/EBPα, C/EBPβ, and ATGL increased (P < 0.05) in FBS + OLA or FBS + LNA cells. Expression of FABP4 and C/EBPβ mRNA was higher in CS, CS + OLA, CS + LNA, CS + PAM, or CS + STA compared with (FBS, whereas the expression of ATGL and C/EBPα was higher in CS, CS + OLA, or CS + LNA than FBS cells. In conclusion, these results showed that FA have different potentials to induce adipogenesis, LNA is the most potent among the tested FA, and these potentials can be improved in the presence of CS.
28523479	0	11	Fatty Acids	T109	C0015684
28523479	17	26	Different	T080	C1705242
28523479	27	53	Adipogenic Differentiation	T044	C0596843
28523479	54	64	Potentials	T080	C3245505
28523479	68	90	Stromal Vascular Cells	T025	C0162597
28523479	91	99	Isolated	T169	C0205409
28523479	105	118	Abdominal Fat	T024	C1563742
28523479	122	128	Laying	T040	C1622979
28523479	129	133	Hens	T012	C0008051
28523479	139	144	study	T062	C2603343
28523479	174	184	effects of	T080	C1704420
28523479	185	196	fatty acids	T109	C0015684
28523479	198	200	FA	T109	C0015684
28523479	215	228	chicken serum	T129	C1440440
28523479	230	232	CS	T129	C1440440
28523479	241	251	expression	T045	C0017262
28523479	255	265	adipogenic	T044	C0596843
28523479	266	277	transcripts	T114	C1519595
28523479	282	294	adipogenesis	T044	C0596843
28523479	298	305	chicken	T012	C0008051
28523479	306	328	stromal vascular cells	T025	C0162597
28523479	330	333	SVC	T025	C0162597
28523479	353	356	SVC	T025	C0162597
28523479	371	375	DMEM	T121	C1665363
28523479	391	394	FBS	T130	C3812213
28523479	396	403	Control	T096	C0009932
28523479	409	416	treated	T169	C1522326
28523479	429	439	oleic acid	T109,T121	C0028928
28523479	441	444	OLA	T109,T121	C0028928
28523479	448	451	FBS	T130	C3812213
28523479	453	466	linoleic acid	T109,T121,T123	C0023749
28523479	468	471	LNA	T109,T121,T123	C0023749
28523479	475	478	FBS	T130	C3812213
28523479	480	493	palmitic acid	T109,T123	C0030234
28523479	495	498	PAM	T109,T123	C0030234
28523479	502	505	FBS	T130	C3812213
28523479	510	522	stearic acid	T109,T121	C0038229
28523479	524	527	STA	T109,T121	C0038229
28523479	531	534	FBS	T130	C3812213
28523479	562	567	cells	T025	C0007634
28523479	582	586	DMEM	T121	C1665363
28523479	601	603	CS	T129	C1440440
28523479	608	615	treated	T169	C1522326
28523479	628	631	OLA	T109,T121	C0028928
28523479	633	635	CS	T129	C1440440
28523479	638	641	OLA	T109,T121	C0028928
28523479	644	647	PAM	T109,T123	C0030234
28523479	649	651	CS	T129	C1440440
28523479	654	657	PAM	T109,T123	C0030234
28523479	660	663	STA	T109,T121	C0038229
28523479	665	667	CS	T129	C1440440
28523479	670	673	STA	T109,T121	C0038229
28523479	685	688	LNA	T109,T121,T123	C0023749
28523479	690	692	CS	T129	C1440440
28523479	695	698	LNA	T109,T121,T123	C0023749
28523479	710	722	Adipogenesis	T044	C0596843
28523479	744	762	Oil Red O staining	T059	C1294000
28523479	767	817	glycerol-3-phosphate dehydrogenase (GPDH) activity	T044	C1151278
28523479	837	840	OLA	T109,T121	C0028928
28523479	842	845	PAM	T109,T123	C0030234
28523479	850	853	STA	T109,T121	C0038229
28523479	858	867	increased	T081	C0205217
28523479	882	885	SVC	T025	C0162597
28523479	902	905	FBS	T130	C3812213
28523479	909	911	CS	T129	C1440440
28523479	917	920	OLA	T109,T121	C0028928
28523479	922	925	PAM	T109,T123	C0030234
28523479	929	932	STA	T109,T121	C0038229
28523479	934	946	Adipogenesis	T044	C0596843
28523479	951	958	induced	T169	C0205263
28523479	962	965	FBS	T130	C3812213
28523479	968	971	OLA	T109,T121	C0028928
28523479	973	976	FBS	T130	C3812213
28523479	979	982	LNA	T109,T121,T123	C0023749
28523479	984	987	FBS	T130	C3812213
28523479	990	993	PAM	T109,T123	C0030234
28523479	995	998	FBS	T130	C3812213
28523479	1001	1004	STA	T109,T121	C0038229
28523479	1006	1008	CS	T129	C1440440
28523479	1011	1014	OLA	T109,T121	C0028928
28523479	1016	1018	CS	T129	C1440440
28523479	1021	1024	LNA	T109,T121,T123	C0023749
28523479	1026	1028	CS	T129	C1440440
28523479	1031	1034	PAM	T109,T123	C0030234
28523479	1039	1041	CS	T129	C1440440
28523479	1044	1047	STA	T109,T121	C0038229
28523479	1060	1063	FBS	T130	C3812213
28523479	1065	1078	GPDH activity	T044	C1151278
28523479	1083	1103	significantly higher	T081	C4055637
28523479	1107	1110	FBS	T130	C3812213
28523479	1113	1116	OLA	T109,T121	C0028928
28523479	1121	1124	FBS	T130	C3812213
28523479	1127	1130	LNA	T109,T121,T123	C0023749
28523479	1143	1146	FBS	T130	C3812213
28523479	1160	1163	FBS	T130	C3812213
28523479	1169	1179	expression	T045	C0017262
28523479	1183	1188	FABP4	T028	C1333527
28523479	1189	1193	mRNA	T114,T123	C0035696
28523479	1194	1203	increased	T081	C0205217
28523479	1218	1221	FBS	T130	C3812213
28523479	1224	1227	OLA	T109,T121	C0028928
28523479	1229	1232	FBS	T130	C3812213
28523479	1235	1238	LNA	T109,T121,T123	C0023749
28523479	1243	1246	FBS	T130	C3812213
28523479	1249	1252	PAM	T109,T123	C0030234
28523479	1270	1276	C/EBPα	T028	C1413322
28523479	1278	1284	C/EBPβ	T028	C1413323
28523479	1290	1294	ATGL	T028	C1538686
28523479	1295	1304	increased	T081	C0205217
28523479	1319	1322	FBS	T130	C3812213
28523479	1325	1328	OLA	T109,T121	C0028928
28523479	1332	1335	FBS	T130	C3812213
28523479	1338	1341	LNA	T109,T121,T123	C0023749
28523479	1342	1347	cells	T025	C0007634
28523479	1349	1359	Expression	T045	C0017262
28523479	1363	1368	FABP4	T028	C1333527
28523479	1373	1379	C/EBPβ	T028	C1413323
28523479	1380	1384	mRNA	T114,T123	C0035696
28523479	1389	1395	higher	T080	C0205250
28523479	1399	1401	CS	T129	C1440440
28523479	1403	1405	CS	T129	C1440440
28523479	1408	1411	OLA	T109,T121	C0028928
28523479	1413	1415	CS	T129	C1440440
28523479	1418	1421	LNA	T109,T121,T123	C0023749
28523479	1423	1425	CS	T129	C1440440
28523479	1428	1431	PAM	T109,T123	C0030234
28523479	1436	1438	CS	T129	C1440440
28523479	1441	1444	STA	T109,T121	C0038229
28523479	1445	1453	compared	T052	C1707455
28523479	1460	1463	FBS	T130	C3812213
28523479	1477	1487	expression	T045	C0017262
28523479	1491	1495	ATGL	T028	C1538686
28523479	1500	1506	C/EBPα	T028	C1413322
28523479	1511	1517	higher	T080	C0205250
28523479	1521	1523	CS	T129	C1440440
28523479	1525	1527	CS	T129	C1440440
28523479	1530	1533	OLA	T109,T121	C0028928
28523479	1538	1540	CS	T129	C1440440
28523479	1543	1546	LNA	T109,T121,T123	C0023749
28523479	1552	1555	FBS	T130	C3812213
28523479	1556	1561	cells	T025	C0007634
28523479	1584	1591	results	T033	C2825142
28523479	1604	1606	FA	T109	C0015684
28523479	1612	1621	different	T080	C1705242
28523479	1622	1632	potentials	T080	C3245505
28523479	1636	1642	induce	T169	C0205263
28523479	1643	1655	adipogenesis	T044	C0596843
28523479	1657	1660	LNA	T109,T121,T123	C0023749
28523479	1673	1679	potent	T080	C3245505
28523479	1697	1699	FA	T109	C0015684
28523479	1711	1721	potentials	T080	C3245505
28523479	1745	1753	presence	T033	C0150312
28523479	1757	1759	CS	T129	C1440440